10-Q Filing

NEOGENOMICS INC CIK: 1077183 Q1 2017

Filing Information

Form Type	10-Q
Accession Number	`0001564590-17-009543`
Period End Date	20170331
Filing Date	20170509
Fiscal Year	2017
Fiscal Period	Q1
XBRL Instance	neo-20170331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 81 Income Statement 42 Cash Flow Statement 59

Balance Sheet 81 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivable`	$13.70M	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivable`	$14.64M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$27.10M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$31.01M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.26M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.04M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.53M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$23.42M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $14,644 and $13,699, respectively)	`AccountsReceivableNetCurrent`	$55.51M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $14,644 and $13,699, respectively)	`AccountsReceivableNetCurrent`	$61.72M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Inventories	`InventoryNet`	$5.97M	USD	Point-in-time
Inventories	`InventoryNet`	$6.25M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	78.57M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	79.21M	shares	Point-in-time
Other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.86M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	78.57M	shares	Point-in-time
Other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.54M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	79.21M	shares	Point-in-time
Redeemable Convertible Preferred Stock, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Redeemable Convertible Preferred Stock, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$84.58M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$78.83M	USD	Point-in-time
Property and equipment (net of accumulated depreciation of $31,012 and $27,102, respectively)	`PropertyPlantAndEquipmentNet`	$34.04M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares authorized	`TemporaryEquitySharesAuthorized`	50.00M	shares	Point-in-time
Property and equipment (net of accumulated depreciation of $31,012 and $27,102, respectively)	`PropertyPlantAndEquipmentNet`	$36.53M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares authorized	`TemporaryEquitySharesAuthorized`	50.00M	shares	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$77.06M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares issued	`TemporaryEquitySharesIssued`	6.60M	shares	Point-in-time
Redeemable Convertible Preferred Stock, shares issued	`TemporaryEquitySharesIssued`	6.60M	shares	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$75.34M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares outstanding	`TemporaryEquitySharesOutstanding`	6.60M	shares	Point-in-time
Redeemable Convertible Preferred Stock, shares outstanding	`TemporaryEquitySharesOutstanding`	6.60M	shares	Point-in-time
Goodwill	`Goodwill`	$147.02M	USD	Point-in-time
Goodwill	`Goodwill`	$147.02M	USD	Point-in-time
Goodwill	`Goodwill`	$147.02M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$167.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$174.00K	USD	Point-in-time
Total assets	`Assets`	$337.12M	USD	Point-in-time
Total assets	`Assets`	$343.64M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$20.58M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$16.78M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$7.70M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$8.35M	USD	Point-in-time
Accrued expenses and other liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$2.77M	USD	Point-in-time
Accrued expenses and other liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$4.25M	USD	Point-in-time
Short-term portion of capital leases	`CapitalLeaseObligationsCurrent`	$4.89M	USD	Point-in-time
Short-term portion of capital leases	`CapitalLeaseObligationsCurrent`	$5.00M	USD	Point-in-time
Short-term portion of loans	`SecuredDebtCurrent`	$3.84M	USD	Point-in-time
Short-term portion of loans	`SecuredDebtCurrent`	$3.84M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$39.88M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$38.11M	USD	Point-in-time
Long-term portion of capital leases	`CapitalLeaseObligationsNoncurrent`	$5.38M	USD	Point-in-time
Long-term portion of capital leases	`CapitalLeaseObligationsNoncurrent`	$5.93M	USD	Point-in-time
Long-term portion of loans, net	`SecuredLongTermDebt`	$69.36M	USD	Point-in-time
Long-term portion of loans, net	`SecuredLongTermDebt`	$70.26M	USD	Point-in-time
Revolving credit facility, net	`LongTermLineOfCredit`	$26.86M	USD	Point-in-time
Revolving credit facility, net	`LongTermLineOfCredit`	$21.80M	USD	Point-in-time
Deferred income tax liability, net	`DeferredTaxLiabilities`	$7.58M	USD	Point-in-time
Deferred income tax liability, net	`DeferredTaxLiabilities`	$14.97M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$112.41M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$109.74M	USD	Point-in-time
Total liabilities	`Liabilities`	$150.52M	USD	Point-in-time
Total liabilities	`Liabilities`	$149.61M	USD	Point-in-time
Commitments and contingencies - see Note I	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies - see Note I	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series A Redeemable Convertible Preferred Stock, $0.001 par value, (50,000,000 shares authorized; and 6,600,000 shares issued and outstanding, respectively)	`RedeemableNoncontrollingInterestEquityPreferredCarryingAmount`	$25.44M	USD	Point-in-time
Series A Redeemable Convertible Preferred Stock, $0.001 par value, (50,000,000 shares authorized; and 6,600,000 shares issued and outstanding, respectively)	`RedeemableNoncontrollingInterestEquityPreferredCarryingAmount`	$22.87M	USD	Point-in-time
Common stock, $0.001 par value, (250,000,000 shares authorized; 79,206,945 and 78,571,158 shares issued and outstanding, respectively)	`CommonStockValueOutstanding`	$79.00K	USD	Point-in-time
Common stock, $0.001 par value, (250,000,000 shares authorized; 79,206,945 and 78,571,158 shares issued and outstanding, respectively)	`CommonStockValueOutstanding`	$79.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$216.10M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$217.63M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-52.46M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-49.12M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$163.72M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$168.59M	USD	Point-in-time
Total liabilities, redeemable convertible preferred stock and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$343.64M	USD	Point-in-time
Total liabilities, redeemable convertible preferred stock and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$337.12M	USD	Point-in-time

Income Statement 42 line items

Line Item	Tag	Value	Unit	Period
Clinical testing	`ClinicalTestingRevenue`	$54.62M	USD	1 Quarter
Clinical testing	`ClinicalTestingRevenue`	$56.69M	USD	1 Quarter
Pharma Services	`PharmaServices`	$4.99M	USD	1 Quarter
Pharma Services	`PharmaServices`	$5.08M	USD	1 Quarter
Total Revenue	`SalesRevenueServicesNet`	$61.68M	USD	1 Quarter
Total Revenue	`SalesRevenueServicesNet`	$59.70M	USD	1 Quarter
COST OF REVENUE	`CostOfServices`	$34.48M	USD	1 Quarter
COST OF REVENUE	`CostOfServices`	$32.53M	USD	1 Quarter
GROSS MARGIN	`GrossProfit`	$27.17M	USD	1 Quarter
GROSS MARGIN	`GrossProfit`	$27.20M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$20.80M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$18.00M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.45M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$862.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$5.80M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$5.65M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$27.31M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$25.25M	USD	1 Quarter
INCOME (LOSS) FROM OPERATIONS	`OperatingIncomeLoss`	$1.92M	USD	1 Quarter
INCOME (LOSS) FROM OPERATIONS	`OperatingIncomeLoss`	$-115.00K	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-1.36M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-1.59M	USD	1 Quarter
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$329.00K	USD	1 Quarter
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.48M	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$-825.00K	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$174.00K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-654.00K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$155.00K	USD	1 Quarter
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$1.84M	USD	1 Quarter
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$894.00K	USD	1 Quarter
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$3.73M	USD	1 Quarter
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$1.67M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.41M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.22M	USD	1 Quarter
Basic	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.04	USD	1 Quarter
Basic	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.07	USD	1 Quarter
Diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.04	USD	1 Quarter
Diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.07	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	76.07M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	78.65M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	76.07M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	78.65M	shares	1 Quarter

Cash Flow Statement 59 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-654.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$155.00K	USD	1 Quarter
Depreciation	`Depreciation`	$3.58M	USD	1 Quarter
Depreciation	`Depreciation`	$3.98M	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.73M	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$2.03M	USD	1 Quarter
Amortization of debt issue costs	`AmortizationOfFinancingCosts`	$110.00K	USD	1 Quarter
Amortization of debt issue costs	`AmortizationOfFinancingCosts`	$182.00K	USD	1 Quarter
Stock based compensation options, restricted stock and warrants	`ShareBasedCompensationAndWarrants`	$703.00K	USD	1 Quarter
Stock based compensation options, restricted stock and warrants	`ShareBasedCompensationAndWarrants`	$1.13M	USD	1 Quarter
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$3.78M	USD	1 Quarter
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$2.66M	USD	1 Quarter
(Increase) in accounts receivable, net of write-offs	`IncreaseDecreaseInAccountsReceivable`	$3.81M	USD	1 Quarter
(Increase) in accounts receivable, net of write-offs	`IncreaseDecreaseInAccountsReceivable`	$9.99M	USD	1 Quarter
(Increase) decrease in inventories	`IncreaseDecreaseInInventories`	$225.00K	USD	1 Quarter
(Increase) decrease in inventories	`IncreaseDecreaseInInventories`	$-283.00K	USD	1 Quarter
(Increase) in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$401.00K	USD	1 Quarter
(Increase) in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$1.32M	USD	1 Quarter
Decrease in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-6.00K	USD	1 Quarter
Increase (decrease) in accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$2.18M	USD	1 Quarter
Increase (decrease) in accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$-738.00K	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-1.69M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$7.06M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.01M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-3.01M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-1.00M	USD	1 Quarter
Advances from revolving credit facility, net	`ProceedsFromLinesOfCredit`	$5.01M	USD	1 Quarter
Repayment to revolving credit facility	`RepaymentsOfLinesOfCredit`	$10.04M	USD	1 Quarter
Repayment of capital lease obligations/loans	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$1.37M	USD	1 Quarter
Repayment of capital lease obligations/loans	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$1.26M	USD	1 Quarter
Repayment on term loan, net	`RepaymentsOfLongTermLinesOfCredit`	$7.00K	USD	1 Quarter
Repayment on term loan, net	`RepaymentsOfLongTermLinesOfCredit`	$932.00K	USD	1 Quarter
Issuance of common stock for the exercise of options, warrants and ESPP shares	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$505.00K	USD	1 Quarter
Issuance of common stock for the exercise of options, warrants and ESPP shares	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$1.30M	USD	1 Quarter
Payments of equity issue costs	`PaymentsOfStockIssuanceCosts`	$112.00K	USD	1 Quarter
Payments of equity issue costs	`PaymentsOfStockIssuanceCosts`	$97.00K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$3.20M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-10.22M	USD	1 Quarter
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.49M	USD	1 Quarter
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-4.16M	USD	1 Quarter
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$19.26M	USD	Point-in-time
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$11.04M	USD	Point-in-time
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$12.53M	USD	Point-in-time
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$23.42M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$19.26M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$11.04M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$12.53M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$23.42M	USD	Point-in-time
Interest paid	`InterestPaid`	$1.42M	USD	1 Quarter
Interest paid	`InterestPaid`	$1.26M	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaid`	$5.00K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaid`	$207.00K	USD	1 Quarter
Equipment acquired under capital lease/loan obligations	`CapitalLeaseObligationsIncurred`	$173.00K	USD	1 Quarter
Equipment acquired under capital lease/loan obligations	`CapitalLeaseObligationsIncurred`	$1.90M	USD	1 Quarter
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$1.84M	USD	1 Quarter
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$894.00K	USD	1 Quarter
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$3.73M	USD	1 Quarter
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$1.67M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.